LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 51 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $5,414,000 | -58.2% | 5,437 | -56.3% | 0.50% | -60.5% |
Q1 2021 | $12,966,000 | +265.2% | 12,437 | +232.3% | 1.27% | +161.5% |
Q4 2020 | $3,550,000 | +5.2% | 3,743 | -99.9% | 0.49% | -33.8% |
Q3 2020 | $3,376,000 | -39.4% | 3,743,000 | -41.1% | 0.73% | -66.1% |
Q2 2020 | $5,569,000 | +183.0% | 6,350,000 | +170.2% | 2.17% | +93.9% |
Q1 2020 | $1,968,000 | -3.0% | 2,350,000 | 0.0% | 1.12% | +9.9% |
Q4 2019 | $2,028,000 | -54.5% | 2,350,000 | -56.1% | 1.02% | -59.8% |
Q3 2019 | $4,459,000 | +281.4% | 5,350,000 | +296.3% | 2.53% | +272.7% |
Q2 2019 | $1,169,000 | – | 1,350,000 | – | 0.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Penn Mutual Asset Management | 1,214,000 | $1,164,000 | 1.57% |
TFG Asset Management GP Ltd | 21,600,000 | $21,027,000 | 1.44% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,336,000 | 0.26% |
OAKTREE CAPITAL MANAGEMENT LP | 20,472,000 | $19,704,000 | 0.23% |
PALISADE CAPITAL MANAGEMENT, LP | 5,952,000 | $5,782,000 | 0.16% |
SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,916,000 | 0.12% |
Cutler Capital Management, LLC | 300,000 | $287,000 | 0.11% |
Radcliffe Capital Management, L.P. | 3,117,000 | $2,985,000 | 0.07% |
PROSPECTOR PARTNERS LLC | 400,000 | $383,000 | 0.06% |
Financial Sense Advisors, Inc. | 130,000 | $125,000 | 0.05% |